To determine in vivo whether EBERs could promote tumor growth through TLR3 signaling pathways, we used TLR3 knockout mice (TLR3−/−) to verify the impact of EBERs on growth of syngeneic tumor (B16, mouse melanoma cells). The gene discussed is TLR3; the disease is melanoma.